TED.L Regulatory News (TED)

15 Jul 2005 07:00

Tepnel Life Sciences PLC14 July 2005 Tepnel Life Sciences plc ("the Company") Holding in Company The Company received notification on 12 July 2005 that on 12 July 2005 OrbiMedCapital LLC ("OrbiMed"), through its investment management discretion over thesecurities owned by Finsbury Emerging Biotechnology Trust plc (formerly Finsbury Life Sciences Investment Trust plc) sold 3,120,696 ordinary shares of1p each in the Company ("Ordinary Shares"). OrbiMed also has investmentmanagement discretion over the securities owned by Finsbury Worldwide Pharmaceutical Trust plc, which is a registered owner of 37,000,000 OrdinaryShares. OrbiMed are now therefore interested in 47,000,000 Ordinary Shares,representing approximately 22.07 per cent of the issued share capital of the Company. This information is provided by RNS The company news service from the London Stock Exchange